The Science Behind Monoclonal Antibodies: What Neurologists Need to Know
This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporation.
Click Here to Read the Content.
Topics in this content include:
- Target-related and non-specific toxicity of therapeutic monoclonal antibodies (mAbs)
- Research in antibody-based therapeutics
- Differences between therapeutic mAbs and small-molecule therapies
USA-334-80408
,